Avanos Medical, Inc. · Brief

Next report

Today

Nov 3 · before openest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

1 of 8≥ implied

Jul 31 '24±8.6%▲+4.18%×0.49

Oct 30 '24±12.3%▼−17.90%×1.46

Feb 26 '25±7.3%▲+0.39%×0.05

May 6 '25±8.8%▲+5.41%×0.61

Aug 5 '25±16.0%▼−12.09%×0.75

Q3 FY25±23.8%▼−5.66%×0.24

Feb 24 '26±18.4%▼−10.44%×0.57

Q1 FY26±2.0%▲+0.16%×0.08

quarterimplied−25%0+25%realized×

Q1 FY26±2.0%▲+0.16%×0.08

Feb '26±18.4%▼−10.44%×0.57

Q3 FY25±23.8%▼−5.66%×0.24

Aug '25±16.0%▼−12.09%×0.75

May '25±8.8%▲+5.41%×0.61

Feb '25±7.3%▲+0.39%×0.05

2 older reports

Oct '24±12.3%▼−17.90%×1.46

Jul '24±8.6%▲+4.18%×0.49

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 3 report · est.

Bull2

281managers reporting a position in the latest quarterly filings13F · Jun 30 '26

4 of 13largest reporting managers that cut their stake in the latest quarter13F · Jun 30 '26

Bear2

15.00%revenue from the largest disclosed customer Medline IndustriesSEC filings

7 of 8recent reports where the move came in under the options implied rangeEarnings history

AI captions · Nov 2 '26once per report · top 2 per case

AVNS report session

No linked exposure.

No changes.

privateThesis 0 · Decisions 0 · Observations 0

No thesis.